SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

RAGE GUY (RAGE) is a cryptocurrency inspired by the Rage Guy meme, one of the earliest and most recognizable characters from internet rage comics. The project captures the cultural legacy of early meme history and brings it onto the blockchain in tokenized form. It is designed as a community-driven digital asset that celebrates internet culture, nostalgia, and the role memes play in shaping online communities.

Rage Guy

RAGE is trending as the community rallies around the OG meme coin, anticipating potential listings and partnerships. Discussions are centered on community building and expressing bullish sentiment, emphasizing the coin's potential within the meme culture landscape. The community is actively participating in raids and spaces, further amplifying the coin's visibility.

Memecoin on Cronos launched by the Cro Crow community

crow with knife

Crow with Knife ($CAW) is gaining attention as a multichain meme coin, with its community emphasizing its deflationary mechanism and organic growth. Discussions highlight its presence on multiple chains like Solana, CRO, and Base, with some suggesting staking opportunities may be coming. The community is actively using "caw caw caw" to express their excitement.

Bounce Token

Bounce Token is experiencing heightened interest as the community anticipates a potential breakout, drawing comparisons to previous rallies. Discussions revolve around promising utility, growing bid sizes, and possible integration with AI, with some community members pointing to bullish technical indicators. Despite some skepticism, there's optimism for a significant run, with attention focused on key price levels.

Algorand is a scalable, secure, and decentralized digital currency and smart contract platform. Its protocol uses a variation of Proof-of-Stake (PoS) called Pure PoS (PPoS) to secure the network and reach consensus on block production. Developers can build decentralized applications (dApps) using familiar programming languages, including Python, which Algorand supports natively. Its infrastructure enables various use cases, including payment systems, digital identity solutions, supply-chain tracking, and financial services. The protocol's architecture allows for tokenization of assets and the development of smart contracts, while its technical specifications support both retail users seeking basic transaction capabilities and enterprises requiring more, complex, blockchain solutions.

Algorand

Algorand is trending as the community discusses its potential, quantum-resistant technology, and real-world asset tokenization. Bullish sentiment is fueled by anticipation of alt season and speculation around partnerships, while some express frustration with the current price action and the Algorand Foundation. Chatter also includes commentary about specific users and their past predictions.

iShares Bitcoin Trust ETF - iShares Bitcoin Trust Beneficial Interest

iShares Bitcoin ETF

IBIT is trending amid discussions about potential catalysts for Bitcoin, including possible government actions and favorable seasonal patterns. Community members are actively debating entry points and whether IBIT offers a better risk/reward profile compared to holding Bitcoin directly or investing in companies with Bitcoin on their balance sheets. Some traders are highlighting options activity suggesting bullish sentiment, while others remain cautious.

Cronos is an institutional-grade, high-performance, EVM-compatible Layer-1 blockchain built on the Cosmos SDK and integrated with the Inter-Blockchain Communication (IBC) protocol, designed as the backbone for open, compliant, and AI-accessible tokenized markets. It supports up to 60,000 transactions per second (TPS), 500ms block times, instant finality, and sub-$0.01 fees via Proof of Authority consensus.

Crypto.com Coin

Crypto.com Coin is trending as the community discusses the project "crow with knife" ($CAW) and its potential impact on CRO. Some investors express frustration with CRO's price action and concerns about its performance relative to other cryptocurrencies, while others remain optimistic, citing potential catalysts and partnerships.

Pojak watched as the world played hot potato with CTO shit coins. Now, it's his moment. With Pepe's legendary meme power and Wojak's emotional depth, Pojak brings a new level of influence, wealth, and ethics. Born into meme royalty with luxury and wisdom from Pepe and Wojak, he faced hardship when the original developer rugged the project. The community rose up and took control. Pojak was reborn, stronger and more determined.

Pojak

Pojak ($PJ) is trending as the community buzzes about its integration with Phantom Wallet, fueling excitement. Discussions highlight the potential for a breakout and "moon" run, with many claiming bags are loaded. Some users suggest caution, comparing it to other hyped coins.

Shiba Inu (SHIB) is a meme token which began as a fun currency and has now transformed into a decentralized ecosystem. During the initial launch, 50% of the supply was allocated into Vitalik Buterin's ethereum wallet.   As a result of that, Vitalik proceeded to donate 10% of his SHIB holdings to a COVID-19 relief effort in India and the remaining 40% is burnt forever. That donation was worth about $1 billion at that time, which makes it one of the largest donation ever in the world.  What is the Shiba Inu community working on right now? The Shiba Inu team launched a decentralized exchange called Shibaswap with 2 new tokens, LEASH and BONE. LEASH is a scarce supply token that is used to offer incentives on Shibaswap. BONE is the governance token for holders to vote on proposals on Doggy DAO.

Shiba Inu

Shiba Inu is trending amidst mixed sentiments, with some community members expressing frustration over its past performance while others remain optimistic, calling for patience and a focus on long-term potential. Discussions include potential price movements and comparisons to other meme coins. The broader conversation also touches upon the overall state of the crypto market and potential market manipulation.

A composable native asset bridge with unified liquidity and instant guaranteed finality

Stargate

Stargate is trending as community members discuss its role in bridging and burning $CAW tokens across multiple blockchains. Some users highlight a recent acquisition deal with $ZRO, while others are drawn to Stargate's integration with Hyperliquid for one-click deposits. The community is actively bridging, burning, and following the crow with knife.

MLN is the official token of Enzyme. Founded in 2017, Enzyme is the global infrastructure for tokenized finance. Enzyme provides industry leaders with a comprehensive suites of Vault-As-A-Service and Financial Instruments products to manage on-chain assets efficiently, optimize operational processes, and develop innovative financial strategies tailored to their unique goals and challenges.

Melon

Recent price action and low supply are sparking increased interest in MLN, with some community members drawing comparisons to other coins with explosive growth potential. Conversations revolve around identifying potential entry points and anticipating a significant upward move. Some traders caution about potential pump and dump schemes.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Galectin Therapeutics Inc. (GALT) Is Up 7.48% in One Week: What You Should Know 

Does Galectin Therapeutics Inc. (GALT) have what it takes to be a top stock pick for momentum investors? Let's find out.

Biotech stocks, particularly in the small- and mid-cap space, were hot topics among retail investors in 2024, often spurred by major announcements or clinical developments.&nbsp;Collectively, these stocks attracted significant chatter on Stocktwits.&nbsp;Here are the top five biotech stocks with the highest message volume growth this year:Tonix Pharmaceuticals Holding Corp. (TNXP): +47,066% Message VolumeTonix focuses on developing therapies to treat and prevent diseases. Its TNX-102 SL, a non-opioid analgesic for fibromyalgia, gained attention when the FDA&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/govx-tnpx-ebs-siga-stocks-face-mixed-signals-on-mpox-news/c7voqTBRTH">accepted</a> its New Drug Application in December. Earlier in the year, the company also reiterated its&nbsp;<a href="https://stocktwits.com/news-articles/markets/5/tnxp-stocktwits-chatter-explodes-after-fda-nod-for-nda/cJaVYSzR1F">commitment</a> to developing an mpox vaccine. Despite these milestones, TNXP shares are down over 97% this year.Candel Therapeutics Inc. (CADL): +16,000% Message VolumeCandel develops viral immunotherapies targeting cancer. Its lead product, CAN-2409, is under trial for various cancers, including prostate and non-small cell lung cancer. Positive late-stage&nbsp;<a href="https://stocktwits.com/news-articles/markets/5/cadl-stock-soars-after-prostate-cancer-drug-trial-data/cJa3iD5R0a">results</a> released this month for CAN-2409 in prostate cancer drove retail interest. Shares of CADL are up over 500% this year.Cardio Diagnostics Holdings Inc. (CDIO): +11,650% Message VolumeCardio Diagnostics gained traction with its AI-powered PrecisionCHD test for coronary heart disease. The test demonstrated significant cost-saving potential in healthcare, according to the company. Cardio also received final pricing determinations from the Centers for Medicare &amp; Medicaid Services for its products. Its stock has fallen nearly 63% year-to-date.Recursion Pharmaceuticals Inc. (RXRX): +9,600% Message VolumeRecursion uses AI and automation to discover medicines. A $50 million investment from Nvidia to support AI-driven drug discovery efforts primarily sparked significant retail interest this year, although RXRX shares have declined 22% so far in 2024.Galectin Therapeutics Inc. (GALT): +5,800% Message VolumeGalectin’s focus on fibrotic and inflammatory diseases, led by its drug belapectin, caught investors’ attention despite mixed trial results. While the drug didn’t meet statistical significance for a key endpoint in an early liver disease trial, further data analysis is expected in early 2025. GALT shares are down over 48% this year.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Hand holding test tube over stock data on computer monitor. | Image source: Getty Images

Top 5 Biotech Stocks Dominating Retail Investor Conversations In 2024

From Tonix Pharmaceuticals’ progress on fibromyalgia treatments to Nvidia-backed Recursion Pharmaceuticals, these stocks sparked significant message volume growth on Stocktwits.

Equity

Galectin Therapeutics And 2 Other Stocks Under $5 Insiders Are Buying

FY2025 EPS Estimates for Galectin Therapeutics Inc. Lowered by Analyst (NASDAQ:GALT)

Galectin Therapeutics Inc. (NASDAQ:GALT - Free Report) - Research analysts at HC Wainwright lowered their FY2025 EPS estimates for shares of Galectin Therapeutics in a report released on Monday...

Retirement Guys Formula LLC Boosts Stock Position in Galectin Therapeutics Inc. (NASDAQ:GALT)

Retirement Guys Formula LLC grew its stake in shares of Galectin Therapeutics Inc. (NASDAQ:GALT - Free Report) by 87.0% during the fourth quarter, according to the company in its most recent 13F...

Galectin Therapeutics (NASDAQ:GALT) Rating Reiterated by HC Wainwright

Galectin Therapeutics (NASDAQ:GALT - Get Free Report)s stock had its "buy" rating reaffirmed by investment analysts at HC Wainwright in a research note issued on Monday, Benzinga reports. They...

Galectin Therapeutics Inc (GALT) Reports 2023 Financial Results and Business Developments

Comparing GALT's Performance Against Analyst Estimates and Exploring Future ProspectsRelated Stocks: GALT...

Galectin Therapeutics GAAP EPS of -$0.74

Galectin Therapeutics GAAP EPS of -$0.74...

Galectin Therapeutics Reports 2023 Financial Results and Provides Business Update

NORCROSS, Ga., March 29, 2024 (GLOBE NEWSWIRE) -- Galectin Therapeutics, Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, today reported financial results...

Galectin Therapeutics (NASDAQ:GALT) Lowered to Sell at StockNews.com

StockNews.com downgraded shares of Galectin Therapeutics (NASDAQ:GALT  Free Report) from a hold rating to a sell rating in a research report report published on Monday. Galectin Therapeutics...

Galectin Therapeutics, Inc. is a biotechnology company, which engages in drug research and development to create new therapies for fibrotic disease, severe skin disease, and cancer. Its programs target the development of carbohydrate molecules which offers alternative options to larger market segments. The company was founded by James C. Czirr and Anatole A. Klyosov on July 10, 2000 and is headquartered in Norcross, GA.

Galectin Therapeutics Inc

Will Netflix ($NFLX) beat quarterly earnings? 
 
*Powered by Polymarket

Stocktwits

Netflix Inc

) beat quarterly earnings? 
 
*Powered by Polymarket

Current Price	$4.99
Prev Close	$5.05
Open	$5.05
Dividend Yield	0.00%
50-Day Moving Average	$4.47
Beta	0.58
Avg. Volume	361,002.62
PE Ratio	-7.75

52-Week High	$6.55
52-Week Low	$0.726
Market Capitalization	$319.66M
EPS (Annual)	-$0.7575
Price to Book	-2.68
Revenue Per Employee	$0.00
Enterprise Value/EBITDA	N/A

GALT
Galectin Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest GALT News

GALTGalectin Therapeutics Inc